Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial.
about
Pregabalin for acute and chronic pain in adultsEvidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and RehabilitatiPharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain SocietySleep Optimization and Diabetes Control: A Review of the LiteratureThe effectiveness of anticonvulsants in psychiatric disordersGuidelines in the management of diabetic nerve pain: clinical utility of pregabalin.Treatment patterns of postherpetic neuralgia patients before and after the launch of pregabalin and its effect on medical costs: Analysis of Japanese claims data provided by Japan Medical Data Center.Breaking down the barriers: fMRI applications in pain, analgesia and analgesics.Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial.Treatment of diabetic sensory polyneuropathy.Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain.Diabetic neuropathy: mechanisms to managementIdentification, prevalence, and treatment of painful diabetic neuropathy in patients from a rural area in South CarolinaTreating Diabetic Neuropathy: Present Strategies and Emerging Solutions.Efficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double-blind placebo-controlled trial.Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial.Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studiesA study of the use of carbamazepine, pregabalin and alpha lipoic acid in patients of diabetic neuropathy.A cost-consequences analysis of the effect of pregabalin in the treatment of peripheral neuropathic pain in routine medical practice in primary care settings.Evidence-based guideline: treatment of painful diabetic neuropathy--report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine & RehabilitationDiabetic neuropathy part 1: overview and symmetric phenotypesPatient-reported-outcomes in subjects with painful lumbar or cervical radiculopathy treated with pregabalin: evidence from medical practice in primary care settings.Integrating data from randomized controlled trials and observational studies to predict the response to pregabalin in patients with painful diabetic peripheral neuropathy.Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain.Dercum's disease (Lipomatosis dolorosa): successful therapy with pregabalin and manual lymphatic drainage and a current overview.Neuromuscular diseases associated with HIV-1 infection.A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD)Diabetic neuropathy: clinical manifestations and current treatments.Pregabalin treatment for peripheral neuropathic pain: a review of safety data from randomized controlled trials conducted in Japan and in the west.Treatment of painful diabetic neuropathyAbuse Potential of Pregabalin: A Systematic Review.EFNS guidelines on pharmacological treatment of neuropathic pain.Antiepileptic drugs in the treatment of neuropathic pain.An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy.Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetineDiabetic neuropathy: new strategies for treatment.Factors predicting adverse events associated with pregabalin administered for neuropathic pain reliefNeuropathic symptoms, quality of life, and clinician perception of patient care in medical oncology outpatients with colorectal, breast, lung, and prostate cancer.A comprehensive drug safety evaluation of pregabalin in peripheral neuropathic pain.Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison.
P2860
Q24239867-52D0E97A-208F-4095-B2C6-C909D2759AD8Q24632313-9A311ACB-DA7E-46D8-8B17-F0F28A4F9C33Q24657295-87C31146-453B-4657-A24B-D40B7774C633Q28395977-5EA74113-622F-4020-99C4-862900F96A92Q28744504-8A0DD6C7-62A6-4DF1-BA32-89243E75A79EQ30537158-A970C55E-1AB0-4D30-90AC-BC081DC7E50AQ31170335-16855A8E-5EF7-40C2-A470-F81552A9B5E3Q33257909-C0CE3E35-DFD4-4FA6-A174-55814C338D73Q33369978-C759C079-7D4B-4319-A100-A9C262DAE713Q33393882-F19C5110-188F-4F8D-A83C-E36293E8AC39Q33408025-17EA956F-F029-4985-9562-5DAC2D42970EQ33554384-834B14C6-F3ED-4F69-AB03-DCA196368E6EQ33563262-F233BF07-BC81-42A8-BC00-6A1DEA79F5A2Q33583006-0647E2AF-43A7-471A-B2D8-F277CBC90D61Q33585572-E0CBE50A-9E20-490A-9685-3A4C84C15691Q33628834-F192002D-7652-4A68-BDF3-26936641A1B4Q33739953-E13678A3-1B8D-4831-ACC9-C07B5896749BQ33747072-03893232-64A3-477B-B740-39649100AB92Q33798640-F443547D-1643-441D-92E2-E3B2C843C1F9Q33870062-B5A7810A-5EB5-4658-B3F1-103CCBFF4AB7Q33878023-3FBECA59-A6EA-4E8D-920B-43C82F8454FDQ33880187-B3F234AD-7452-4A6F-960D-D311566B5CB0Q33921692-100B8BAF-E245-411F-B910-1A8FB3BB6F49Q33949565-D6546C1F-2645-4781-89E9-D95ECABE1561Q34012631-AB77E468-6BB1-4DEB-BE88-B8BF60E65060Q34047113-C2180F83-69F4-4341-9544-18EA19920BC5Q34183517-817400B3-6C45-4A42-906B-7FCD95BB0BFFQ34275990-33AAFD81-E6F0-45C8-88D9-9C76CCB7442BQ34411257-F21CE452-504D-44AA-A231-A8C396B10D59Q34456265-954D5EF1-98E9-41A5-8982-C6F1213F1A0BQ34509031-B2520339-650E-4E2F-B430-722366558178Q34573607-C886A9C3-D2A1-4CD9-AF40-40AA417281E7Q34580010-8F0A8893-5065-4D20-967B-DC2438F4FFD0Q34590272-DB8FD670-1533-4C0C-BB3C-8338040D027CQ34620539-49E1A788-4643-450C-A453-34162EE52E30Q34641965-B3159F0A-6C76-4C01-A431-B43E630EA722Q34756216-424A8AC3-D247-4E81-9240-2D7837E11D55Q35002187-DADBB274-FBA3-4099-AF56-B3EDCDE3989BQ35061149-53AF62A5-7988-46B6-906F-900D2FDAE86FQ35080568-71863BDE-5889-4AAC-84BF-88EB0E53021B
P2860
Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Pregabalin relieves symptoms o ...... a randomized controlled trial.
@en
Pregabalin relieves symptoms o ...... a randomized controlled trial.
@nl
type
label
Pregabalin relieves symptoms o ...... a randomized controlled trial.
@en
Pregabalin relieves symptoms o ...... a randomized controlled trial.
@nl
prefLabel
Pregabalin relieves symptoms o ...... a randomized controlled trial.
@en
Pregabalin relieves symptoms o ...... a randomized controlled trial.
@nl
P2093
P1433
P1476
Pregabalin relieves symptoms o ...... a randomized controlled trial.
@en
P2093
P304
P356
10.1212/01.WNL.0000145767.36287.A1
P407
P577
2004-12-01T00:00:00Z